Resistance to Targeted Agents Used to Treat Paediatric ALK-Positive ALCL

Resistance to Targeted Agents Used to Treat Paediatric ALK-Positive ALCL

Non-Hodgkin lymphoma (NHL) is the third most common malignancy diagnosed in children. The vast majority of paediatric NHL are either Burkitt lymphoma (BL), diffuse large B-cell lymphoma (DLBCL), anaplastic large cell lymphoma (ALCL), or lymphoblastic lymphoma (LL). Multi-agent chemotherapy is used t...

Full description

Bibliographic Details
Main Authors:	Lucy Hare, G. A. Amos Burke, Suzanne D. Turner
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Series:	Cancers
Subjects:	nucleophosmin1-anaplastic lymphoma kinase anaplastic large cell lymphoma resistance chemotherapy paediatric cancer
Online Access:	https://www.mdpi.com/2072-6694/13/23/6003

Similar Items

Three years sustained complete remission achieved in a primary refractory ALK-positive anaplastic T large cell lymphoma treated with crizotinib
by: Carolina Valeria Mahuad, et al.
Published: (2016-06-01)

NPM-ALK: A Driver of Lymphoma Pathogenesis and a Therapeutic Target
by: Elissa Andraos, et al.
Published: (2021-01-01)

From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL)
by: Michael T. Werner, et al.
Published: (2017-10-01)

The Dual Role of Autophagy in Crizotinib-Treated ALK<sup>+</sup> ALCL: From the Lymphoma Cells Drug Resistance to Their Demise
by: Estelle Espinos, et al.
Published: (2021-09-01)

Granulomatous Inflammation in a Patient with ALK-Negative Anaplastic Large Cell Lymphoma
by: Özlem Kandemir Alibakan, et al.
Published: (2022-02-01)

ALK+ Anaplastic large cell lymphoma with extensive cardiac involvement: A rare case report and review of the literature
by: Kaniyappan Nambiyar, et al.
Published: (2021-01-01)

ALK Positive Anaplastic Large Cell Lymphoma Presenting as Extensive Bone Involvement
by: Smeeta Gajendra, et al.
Published: (2015-01-01)

The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL)
by: Ivonne A. Montes-Mojarro, et al.
Published: (2018-04-01)

Analysis of Histologic Features Suspecting Anaplastic Lymphoma Kinase (ALK)-Expressing Pulmonary Adenocarcinoma
by: In Ho Choi, et al.
Published: (2015-07-01)

Anaplastic lymphoma kinase negative anaplastic large cell lymphoma of hard palate as first clinical manifestation of acquired immune deficiency syndrome
by: Anjali Narwal, et al.
Published: (2016-01-01)

A rare case of paediatric non-Hodgkin's lymphoma
by: D Bhargavi, et al.
Published: (2019-01-01)

Anaplastic large T-cell lymphoma: 10-year experience at the National Institute of Neoplastic Diseases, Lima – Peru
by: Cristian Pacheco, et al.
Published: (2022-07-01)

A case of tonsillar anaplastic large cell lymphoma-anaplastic lymphoma kinase negative: An unusual site of involvement with review of literature
by: Umesh Das, et al.
Published: (2014-01-01)

Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma diagnosed in a 90-year-old Japanese woman with simultaneous rearrangements of T-cell receptor and immunoglobulin genes: A case report
by: Kenji Yorita, et al.
Published: (2023-09-01)

MOLECULAR BIOLOGICAL CHARACTERISTICS OF ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA
by: E. V. Chernyshova, et al.
Published: (2017-01-01)

Anaplastic lymphoma kinase–positive anaplastic large cell lymphoma presenting as diffuse pulmonary infiltrates
by: Shuku Sato, et al.
Published: (2020-10-01)

Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma with Cardiac Metastasis and Arterial Tumor Embolisms during First-Course Chemotherapy
by: Kozo Nagai, et al.
Published: (2016-08-01)

Anaplastic Lymphoma Kinase in Cutaneous Malignancies
by: Severine Cao, et al.
Published: (2017-09-01)

Recurrent systemic anaplastic large cell lymphoma: Rapid onset and resolution of cutaneous metastases
by: Jun Long, PhD, et al.
Published: (2020-02-01)

Atractylodin Inhibits Interleukin-6 by Blocking NPM-ALK Activation and MAPKs in HMC-1
by: Hee-Sung Chae, et al.
Published: (2016-09-01)

A Severe Case of Anaplastic Large Cell Lymphoma in a Previously Healthy Woman: Diagnostic and Therapeutic Challenges
by: Petya Angelova, et al.
Published: (2020-12-01)

The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability
by: Cosimo Lobello, et al.
Published: (2018-03-01)

Anaplastic Lymphoma Kinase- and CD30-Positive Anaplastic Large-Cell Lymphoma of the External Auditory Canal
by: Shih-Lung Chen, et al.
Published: (2021-07-01)

ALK+ Anaplastic Large Cell Lymphoma of Null Cell Phenotype with Leukemic Transformation and Leukemoid Reaction
by: Shih-Sung Chuang, et al.
Published: (2019-11-01)

ALK-positive Large B-cell Lymphoma: A Clinicopathologic Retrospective Descriptive Study from a Tertiary Care Cancer Centre in India
by: Jayasudha Arundhathi Vasudevan, et al.
Published: (2023-06-01)

ALK signaling and target therapy in anaplastic large cell lymphoma
by: Fabrizio eTabbo, et al.
Published: (2012-05-01)

A case of primary central nervous system anaplastic lymphoma kinase-positive anaplastic large cell lymphoma in the neurohypophysis and pineal gland
by: Ryo Omae, et al.
Published: (2022-12-01)

A Case of Anaplastic Lymphoma Kinase-positive Large B-cell Lymphoma
by: Gaurav Gupta, et al.
Published: (2019-08-01)

Is breast implant-associated anaplastic large cell lymphoma a hazard of breast implant surgery?
by: Florian Fitzal, et al.
Published: (2019-04-01)

Breast implant-associated anaplastic large cell lymphoma in a Li-FRAUMENI patient: a case report
by: Ricardo Garcia Pastorello, et al.
Published: (2018-01-01)

Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases
by: Komal Agrawal, et al.
Published: (2017-01-01)

Metallic implant-associated lymphoma: ALK-negative anaplastic large cell lymphoma associated with total knee replacement arthroplasty
by: Jai-Hyang Go
Published: (2023-01-01)

Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL)
by: Jun-Ho Lee
Published: (2021-07-01)

ALK-Positive Histiocytosis: A Case Report and Literature Review
by: Omar Issa JABER, et al.
Published: (2021-05-01)

Diagnostic Capability of Next-Generation Sequencing Fusion Analysis in Identifying a Rare CASE of TRAF1-ALK-Associated Anaplastic Large Cell Lymphoma
by: Indu Agarwal, et al.
Published: (2020-05-01)

Immunohistochemical expression of anaplastic lymphoma kinase in neuroblastoma and its relations with some clinical and histopathological features
by: Thu Dang Anh Phan, et al.
Published: (2024-01-01)

Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report
by: Dennis Christoph Harrer, et al.
Published: (2020-10-01)

A Case Report: an EML4-ALK Positive Lung Adenocarcinoma Diagnosed  with Lymphoma Previously
by: Li LIU, et al.
Published: (2015-02-01)

ALK-1 Positive Anaplastic Large Cell Lymphoma Presenting as Extensive and Exclusive Osseous Involvement: Report of a Rare Association and Review of Literature
by: Swetha Lakshmi Narla, et al.
Published: (2018-01-01)

Defining Pathological Activities of ALK in Neuroblastoma, a Neural Crest-Derived Cancer
by: Anna M. Wulf, et al.
Published: (2021-10-01)